Clinical News
eMediNexus Coverage from: 
Baroreflex Device Eases HF Symptoms
eMediNexus,  14 May 2019
remove_red_eye 490 Views
#Business And Medicine #Cardiology #Internal Medicine #Pharmacist

0 Read Comments                

A novel implanted neuromodulation device substantially improved quality of life and functional capacity in heart failure with reduced ejection fraction (HFrEF) in the BeAT-AF study. Baroreflex stimulation with the Barostim Neo device also improved the key prognostic biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP) in the subset of patients with a baseline level of 1,600 pg/mL or less, reflecting less advanced heart failure.Presenting the results a
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!